Ardsley Advisory Partners’s Apollo Endosurgery, Inc. APEN Stock Holding History

Ardsley Advisory Partners’s Portfolio APEN Stock Details APEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-45,188	Closed	-$76K	–	204
2020 Q3	$76K	Hold	45,188	–	–	0.01%	137
2020 Q2	$74K	Sell	45,188 -5,000	-10%	-$9.93K	0.02%	126
2020 Q1	$96K	Hold	50,188	–	–	0.04%	87
2019 Q4	$143K	Hold	50,188	–	–	0.02%	136
2019 Q3	$165K	Buy	50,188 +1,500	+3%	+$4.75K	0.04%	116
2019 Q2	$155K	Hold	48,688	–	–	0.02%	134
2019 Q1	$182K	Buy	48,688 +311	+0.6%	+$1.09K	0.03%	120
2018 Q4	$167K	Sell	48,377 -1,623	-3%	-$8.01K	0.04%	91
2018 Q3	$359K	Hold	50,000	–	–	0.05%	117
2018 Q2	$349K	Buy	50,000 +10,000	+25%	+$62.2K	0.05%	129
2018 Q1	$251K	Buy	40,000 +11,200	+39%	+$70.6K	0.04%	132
2017 Q4	$161K	Buy	28,800 +10,000	+53%	+$45.5K	0.02%	128
2017 Q3	$88K	Buy	+18,800	New	+$99.3K	0.01%	128

Other funds holding APEN

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ardsley Advisory Partners's APEN Position: Q4 2020 in Review

Ardsley Advisory Partners sold out of Apollo Endosurgery, Inc. (APEN) in Q4 2020, closing a stake of 45,188 shares — an estimated $76K sold.

Ardsley Advisory Partners first reported a position in APEN in Q3 2017 and held it in 13 quarters. The position peaked at $359K in Q3 2018. 28 funds tracked by Wall St. Rank hold APEN as of Q4 2020.

Ardsley Advisory Partners reported no remaining Apollo Endosurgery, Inc. position as of Q4 2020 after selling out during the quarter.
Ardsley Advisory Partners sold 45,188 Apollo Endosurgery, Inc. shares in Q4 2020, an estimated $76K.
Ardsley Advisory Partners first reported a position in Apollo Endosurgery, Inc. in Q3 2017 and held it in 13 quarters.
Ardsley Advisory Partners's Apollo Endosurgery, Inc. position peaked at $359K in Q3 2018.
28 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q4 2020.

Based on Ardsley Advisory Partners's 13F filing for Q4 2020, filed 16 Feb 2021.